113 related articles for article (PubMed ID: 30891998)
1. Effects of CD133 on the biological features and
Gao R; Sun TT
J Biol Regul Homeost Agents; 2019 Mar-Apr,; 33(2):355-364. PubMed ID: 30891998
[TBL] [Abstract][Full Text] [Related]
2. [Overexpressed miRNA-134b inhibits proliferation and invasion of CD133
Liu Y; Zhang B; Wen C; Wen G; Zhou G; Zhang J; He H; Wang N; Li W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):637-642. PubMed ID: 28502302
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].
Song WC; Fei XF; Dong J
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405
[TBL] [Abstract][Full Text] [Related]
4. Targeting effect of microRNA on CD133 and its impact analysis on proliferation and invasion of glioma cells.
Zhao C; Ma ZG; Mou SL; Yang YX; Zhang YH; Yao WC
Genet Mol Res; 2017 Mar; 16(1):. PubMed ID: 28362995
[TBL] [Abstract][Full Text] [Related]
5. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
[TBL] [Abstract][Full Text] [Related]
6. Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation.
Ouyang WC; Liao YW; Chen PN; Lu KH; Yu CC; Hsieh PL
Cancer Chemother Pharmacol; 2017 Aug; 80(2):411-419. PubMed ID: 28685346
[TBL] [Abstract][Full Text] [Related]
7. [Chemoresistance of CD133(+) tumor stem cells from human brain glioma].
Bi CL; Fang JS; Chen FH; Wang YJ; Wu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):568-73. PubMed ID: 17767043
[TBL] [Abstract][Full Text] [Related]
8. In vitro neurosphere formation correlates with poor survival in glioma.
C Jayakrishnan P; H Venkat E; M Ramachandran G; K Kesavapisharady K; N Nair S; Bharathan B; Radhakrishnan N; Gopala S
IUBMB Life; 2019 Feb; 71(2):244-253. PubMed ID: 30393962
[TBL] [Abstract][Full Text] [Related]
9. Targeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy.
Sun T; Li Y; Huang Y; Zhang Z; Yang W; Du Z; Zhou Y
Oncotarget; 2016 Jul; 7(28):43095-43108. PubMed ID: 27191269
[TBL] [Abstract][Full Text] [Related]
10. Targeting cancer stem cells through L1CAM suppresses glioma growth.
Bao S; Wu Q; Li Z; Sathornsumetee S; Wang H; McLendon RE; Hjelmeland AB; Rich JN
Cancer Res; 2008 Aug; 68(15):6043-8. PubMed ID: 18676824
[TBL] [Abstract][Full Text] [Related]
11. Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.
Zhang C; Hai L; Zhu M; Yu S; Li T; Lin Y; Liu B; Zhou X; Chen L; Zhao P; Zhou H; Huang Y; Zhang K; Ren B; Yang X
Oncotarget; 2017 May; 8(20):33353-33364. PubMed ID: 28380416
[TBL] [Abstract][Full Text] [Related]
12. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
[TBL] [Abstract][Full Text] [Related]
13. Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells.
Yu SP; Yang XJ; Zhang B; Ming HL; Chen C; Ren BC; Liu ZF; Liu B
Chin Med J (Engl); 2011 Sep; 124(17):2599-604. PubMed ID: 22040410
[TBL] [Abstract][Full Text] [Related]
14. NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma.
Hu PS; Xia QS; Wu F; Li DK; Qi YJ; Hu Y; Wei ZZ; Li SS; Tian NY; Wei QF; Shen LJ; Yin B; Jiang T; Yuan JG; Qiang BQ; Han W; Peng XZ
Oncogene; 2017 Aug; 36(33):4706-4718. PubMed ID: 28394339
[TBL] [Abstract][Full Text] [Related]
15. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
[TBL] [Abstract][Full Text] [Related]
16. The VHL tumor suppressor protein regulates tumorigenicity of U87-derived glioma stem-like cells by inhibiting the JAK/STAT signaling pathway.
Kanno H; Sato H; Yokoyama TA; Yoshizumi T; Yamada S
Int J Oncol; 2013 Mar; 42(3):881-6. PubMed ID: 23338840
[TBL] [Abstract][Full Text] [Related]
17. Phosphoribosylpyrophosphate Synthetase 1 Knockdown Suppresses Tumor Formation of Glioma CD133+ Cells Through Upregulating Cell Apoptosis.
Li C; Yan Z; Cao X; Zhang X; Yang L
J Mol Neurosci; 2016 Oct; 60(2):145-56. PubMed ID: 27343059
[TBL] [Abstract][Full Text] [Related]
18. CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.
Beier D; Wischhusen J; Dietmaier W; Hau P; Proescholdt M; Brawanski A; Bogdahn U; Beier CP
Brain Pathol; 2008 Jul; 18(3):370-7. PubMed ID: 18371181
[TBL] [Abstract][Full Text] [Related]
19. Bufalin Inhibits Cellular Proliferation and Cancer Stem Cell-Like Phenotypes via Upregulation of MiR-203 in Glioma.
Liu T; Wu C; Weng G; Zhao Z; He X; Fu C; Sui Z; Huang SX
Cell Physiol Biochem; 2017; 44(2):671-681. PubMed ID: 29169175
[TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.
Chang CH; Liu WT; Hung HC; Gean CY; Tsai HM; Su CL; Gean PW
BMC Cancer; 2017 Dec; 17(1):905. PubMed ID: 29284440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
